Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma

Experimental Hematology

Volumn 41, Issue 12, 2013, Pages 1028-1037

  Bacher, Ulrike ^a   Kern, Wolfgang ^a   Haferlach, Claudia ^a   Alpermann, Tamara ^a   Haferlach, Torsten ^a   Schnittger, Susanne ^a  

^a MLL MUNICH LEUKEMIA LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLOPHOSPHAMIDE; DOXORUBICIN; MESSENGER RNA; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ABL1 GENE; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYCLIN D1 GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE; GENE EXPRESSION; HAIRY CELL LEUKEMIA; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SPLENIC MARGINAL ZONE LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYCLIN D1; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 84888874239     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.09.004     Document Type: Article

References (32)

1. Dreyling M., Kluin-Nelemans H.C., Bea S., et al. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th Annual Conference of the European Mantle Cell Lymphoma Network. Leuk Lymphoma 2011, 52:2226-2236.
2. Fu K., Weisenburger D.D., Greiner T.C., et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005, 106:4315-4321.
3. Li J.Y., Gaillard F., Moreau A., et al. Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol 1999, 154:1449-1452.
4. Klapper W. Histopathology of mantle cell lymphoma. Semin Hematol 2011, 48:148-154.
5. Swerdlow S.H., Yang W.I., Zukerberg L.R., et al. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol 1995, 26:999-1004.
6. Yatabe Y., Suzuki R., Tobinai K., et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000, 95:2253-2261.
7. Vose J.M. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management. Am J Hematol 2012, 87:604-609.
8. Howe J.G., Crouch J., Cooper D., et al. Real-time quantitative reverse transcription-PCR for cyclin D1 mRNA in blood, marrow, and tissue specimens for diagnosis of mantle cell lymphoma. Clin Chem 2004, 50:80-87.
9. Bijwaard K.E., Aguilera N.S., Monczak Y., et al. Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin Chem 2001, 47:195-201.
10. Weisser M., Haferlach T., Schoch C., et al. The use of housekeeping genes for real-time PCR-based quantification of fusion gene transcripts in acute myeloid leukemia. Leukemia 2004, 18:1551-1553.
11. van der Velden V., Boeckx N., Gonzalez M., et al. Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease-a study within the Europe Against Cancer Program. Leukemia 2004, 18:884-886.
12. Schnittger S., Bacher U., Haferlach T., et al. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia. Blood 2012, 119:3151-3154.
13. Pfeifer H., Wassmann B., Bethge W., et al. Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia. Leukemia 2013, 27:1254-1262.
14. Meggendorfer M, Kern W, Haferlach C, et al. SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis. Leukemia, epub May 7, 2013; doi: http://10.1038/leu.2013.141.
15. Löffler H., Rastetter J., Haferlach T. Atlas of Clinical Hematology, ed 6 2004, Springer, Heidelberg.
16. Kern W., Dicker F., Schnittger S., et al. Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia. Cytometry B Clin Cytom 2009, 76:385-393.
17. Dicker F., Schnittger S., Haferlach T., et al. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression. Blood 2006, 108:3152-3160.
18. Haferlach C., Bacher U. Cytogenetic methods in chronic lymphocytic leukemia. Methods Mol Biol 2011, 730:119-130.
19. Specht K., Kremer M., Muller U., et al. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. Clin Cancer Res 2002, 8:2902-2911.
20. Belaud-Rotureau M.A., Parrens M., Dubus P., et al. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol 2002, 15:517-525.
21. Hui P., Howe J.G., Crouch J., et al. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry. Leuk Lymphoma 2003, 44:1385-1394.
22. Bustin S.A., Benes V., Garson J.A., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622.
23. Beillard E., Pallisgaard N., van der Velden V., et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003, 17:2474-2486.
24. Haferlach C., Dicker F., Schnittger S., et al. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007, 21:2442-2451.
25. Thomazy V.A., Luthra R., Uthman M.O., et al. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas. J Mol Diagn 2002, 4:201-208.
26. Medeiros L.J., Hai S., Thomazy V.A., et al. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas. Mod Pathol 2002, 15:556-564.
27. Brizova H., Kalinova M., Krskova L., et al. Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders. Diagn Mol Pathol 2008, 17:39-50.
28. Bosch F., Jares P., Campo E., et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994, 84:2726-2732.
29. Miranda R.N., Briggs R.C., Kinney M.C., et al. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Mod Pathol 2000, 13:1308-1314.
30. Brizova H., Kalinova M., Krskova L., et al. Quantitative monitoring of cyclin D1 expression: a molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma. Int J Cancer 2008, 123:2865-2870.
31. Andersen N.S., Donovan J.W., Zuckerman A., et al. Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma. Exp Hematol 2002, 30:703-710.
32. Hamborg K.H., Bentzen H.H., Grubach L., et al. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma. Eur J Haematol 2012, 89:385-394.